Skip to main content
Bhavya Doshi, MD, Pediatric Hematology & Oncology, Philadelphia, PA, Hospital of the University of Pennsylvania

BhavyaDoshiMD

Pediatric Hematology & Oncology Philadelphia, PA

Pediatric Coagulation Disorder Hematology

Physician

Dr. Doshi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Doshi's full profile

Already have an account?

Education & Training

  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2015 - 2018
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Pediatrics, 2012 - 2015
  • Emory University School of Medicine
    Emory University School of MedicineClass of 2012, MD

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2015 - 2024
  • GA State Medical License
    GA State Medical License 2012 - 2015
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Member Alpha Omega Alpha, 2011
  • Member Phi Beta Kappa, 2007

Publications & Presentations

PubMed

Journal Articles

  • B Cell Activating Factor Modulates the Factor VIII Immune Response in Hemophilia A  
    Bhavya Doshi, MD, The Journal of Clinical Investigation

Abstracts/Posters

  • Coagulopathy predicts mortality in pediatric traumatic brain injury patients
    Doshi BS, Meeks SL, Hendrickson J, Reisner A, Leong T, Winkler AM, Meyer E, 56th Annual Meeting of American Society of Hematology, San Francisco, CA, 12/2014

Press Mentions

  • B-cell Factor Possible Key to Hemophilia Immune Tolerance
    B-cell Factor Possible Key to Hemophilia Immune ToleranceMay 20th, 2021
  • Key Discovery Could Prevent Treatment Failure in People with Severe Hemophilia A
    Key Discovery Could Prevent Treatment Failure in People with Severe Hemophilia AApril 20th, 2021
  • B Cell Activating Factor Possible Key to Hemophilia Immune Tolerance
    B Cell Activating Factor Possible Key to Hemophilia Immune ToleranceApril 19th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations